Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Multicenter randomized controlled trial of intensive uric acid lowering therapy for CKD patients with hyperuricemia: TARGET-UA ; day:26 ; month:3 ; year:2024 ; pages:1-9
Clinical and experimental nephrology ; (26.3.2024), 1-9
- Urheber
-
Yamamoto, Tetsuya
Kasahara, Masato
Ueshima, Kenji
Uemura, Shiro
Kashihara, Naoki
Kimura, Kenjiro
Konta, Tsuneo
Shoji, Tetsuo
Mima, Akira
Mukoyama, Masashi
Saito, Yoshihiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10157-024-02483-w
- URN
-
urn:nbn:de:101:1-2406121221553.947143969877
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yamamoto, Tetsuya
- Kasahara, Masato
- Ueshima, Kenji
- Uemura, Shiro
- Kashihara, Naoki
- Kimura, Kenjiro
- Konta, Tsuneo
- Shoji, Tetsuo
- Mima, Akira
- Mukoyama, Masashi
- Saito, Yoshihiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
The association of urinary prostaglandins with uric acid in hyperuricemia patients
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia
Association between urinary uric acid excretion and kidney outcome in patients with CKD
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Association between serum uric acid, hyperuricemia and periodontitis: a cross-sectional study using NHANES data
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
The association of urinary prostaglandins with uric acid in hyperuricemia patients
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia
Association between urinary uric acid excretion and kidney outcome in patients with CKD
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout
Association between serum uric acid, hyperuricemia and periodontitis: a cross-sectional study using NHANES data
Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis
The association of urinary prostaglandins with uric acid in hyperuricemia patients
The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
Hyperuricemia Facilitates Uric Acid-Mediated Vascular Endothelial Cell Damage by Inhibiting Mitophagy
Lowering the risk of hyperuricemia and gout is associated with ideal cardiovascular health
Effects of Conventional Uric Acid–Lowering Therapy on Monosodium Urate Crystal Deposits
Cichorium intybus L. promotes intestinal uric acid excretion by modulating ABCG2 in experimental hyperuricemia
Association between urinary uric acid excretion and kidney outcome in patients with CKD
Urate-Lowering Agents in Asymptomatic Hyperuricemia: Role of Urine Sediment Analysis and Musculoskeletal Ultrasound
Impact of hyperuricemia on CKD risk beyond genetic predisposition in a population-based cohort study
Benefits of uric acid-lowering medication after bariatric surgery in patients with gout